or Try an Advanced Search...

    Technical Analysis for GNPX - Genprex, Inc.

    Grade Last Price % Change Price Change
    F 2.47 6.01% 0.14
    GNPX closed down 6.05 percent on Wednesday, May 8, 2024, on 41 percent of normal volume.
    Earnings due: May 22
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical GNPX trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 6.01%
    Wide Bands Range Expansion 6.01%
    Wide Bands Range Expansion -0.40%
    20 DMA Support Bullish -5.51%
    Pocket Pivot Bullish Swing Setup -5.51%
    Wide Bands Range Expansion -5.51%
    Up 3 Days in a Row Strength -5.51%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.23%
    Crossed Above 20 DMA Bullish 1.23%
    Wide Bands Range Expansion 1.23%
    Older End-of-Day Signals for GNPX ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 1 hour ago
    10 DMA Resistance about 1 hour ago
    Rose Above Previous Day's High about 2 hours ago
    Up 5% about 2 hours ago
    10 DMA Support about 3 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    GNPX Chart by TradingView
    Basic chart:

    Profile

    Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Biology Gene Therapy Medical Genetics Applied Genetics Medicinal Chemistry

    Is GNPX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 4 Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up
    Apr 3 Genprex expands clinical trial sites for study to treat small cell lung cancer
    Apr 3 Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer
    Apr 2 Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System
    Mar 19 Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Mar 19 Genprex falls 10% after pricing its offering to raise $6.5M
    Mar 12 Genprex Receives Notice of Patent Grant for Korean Patent Claiming Reqorsa® Immunogene Therapy with PD-1 and PD-L1 Antibodies to Treat Cancers
    Mar 6 Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
    Feb 7 Genprex Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators
    Feb 6 Genprex to Present at Upcoming BIO CEO & Investor Conference
    See more GNPX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 42.4
    52 Week Low 2.09
    Average Volume 56,645
    200-Day Moving Average 10.76
    50-Day Moving Average 3.08
    20-Day Moving Average 2.34
    10-Day Moving Average 2.34
    Average True Range 0.27
    RSI (14) 40.48
    ADX 15.54
    +DI 23.67
    -DI 18.06
    Chandelier Exit (Long, 3 ATRs) 2.42
    Chandelier Exit (Short, 3 ATRs) 2.90
    Upper Bollinger Bands 2.69
    Lower Bollinger Band 1.98
    Percent B (%b) 0.49
    BandWidth 30.13
    MACD Line -0.20
    MACD Signal Line -0.29
    MACD Histogram 0.0892
    Fundamentals Value
    Market Cap 3.46 Million
    Num Shares 1.49 Million
    EPS -24.40
    Price-to-Earnings (P/E) Ratio -0.10
    Price-to-Sales 0.00
    Price-to-Book 0.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.66
    Resistance 3 (R3) 2.67 2.58 2.60
    Resistance 2 (R2) 2.58 2.49 2.57 2.59
    Resistance 1 (R1) 2.45 2.44 2.40 2.44 2.57
    Pivot Point 2.36 2.36 2.33 2.35 2.36
    Support 1 (S1) 2.23 2.27 2.19 2.22 2.09
    Support 2 (S2) 2.14 2.22 2.13 2.07
    Support 3 (S3) 2.01 2.14 2.06
    Support 4 (S4) 2.00